These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 16278380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M.
    Cancer Res; 2000 Nov 01; 60(21):6148-59. PubMed ID: 11085539
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM, Brown KR, Shih W, Wigle DA, Radulovich N, Jurisica I, Tsao MS.
    Oncogene; 2006 Jan 05; 25(1):91-102. PubMed ID: 16158056
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
    Wang HL, Zhang SL, Lu YM, Jiang JY, Zhu XY.
    Ai Zheng; 2006 May 05; 25(5):570-5. PubMed ID: 16687076
    [Abstract] [Full Text] [Related]

  • 7. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S, Kondo S, Shinomura Y, Kanayama S, Miyazaki Y, Kiyohara T, Hiraoka S, Matsuzawa Y.
    Br J Cancer; 2000 Sep 05; 83(5):668-73. PubMed ID: 10944610
    [Abstract] [Full Text] [Related]

  • 8. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
    Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM.
    J Natl Cancer Inst; 2008 Jan 16; 100(2):109-20. PubMed ID: 18182619
    [Abstract] [Full Text] [Related]

  • 10. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C.
    J Natl Cancer Inst; 2011 Apr 20; 103(8):645-61. PubMed ID: 21464397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M, Vitarelli E, Grosso M, Alesci S, Benvenga S, Trimarchi F, Barresi G.
    Eur J Histochem; 2004 Apr 20; 48(3):291-7. PubMed ID: 15590419
    [Abstract] [Full Text] [Related]

  • 14. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J.
    Vet Pathol; 2009 Sep 20; 46(5):869-77. PubMed ID: 19429984
    [Abstract] [Full Text] [Related]

  • 15. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells.
    Moore AE, Greenhough A, Roberts HR, Hicks DJ, Patsos HA, Williams AC, Paraskeva C.
    Carcinogenesis; 2009 Oct 20; 30(10):1796-804. PubMed ID: 19638428
    [Abstract] [Full Text] [Related]

  • 16. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM, Schmitz F, Kiehne K, Stechele HU, Banasiewicz T, Krokowicz P, Nakamura T, Fölsch UR, Herzig K.
    Digestion; 2000 Oct 20; 61(4):237-46. PubMed ID: 10878450
    [Abstract] [Full Text] [Related]

  • 17. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 18. Expression of X-linked inhibitor of apoptosis protein in human colorectal cancer and its correlation with prognosis.
    Xiang G, Wen X, Wang H, Chen K, Liu H.
    J Surg Oncol; 2009 Dec 15; 100(8):708-12. PubMed ID: 19777490
    [Abstract] [Full Text] [Related]

  • 19. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 15; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.